화이자와 BioNTech 코로나19 백신, 긍정적 결과 보여줘
— Wan Ki Choi (@wkchoi) July 1, 2020
- 두 회사가 개발 중인 코로나19 백신의 임상, 건강한 환자에 면역 반응 보여
- 그러나 특히 더 높은 양 투여에서 열과 다른 부작용을 초래해
- 첫 임상 데이터, 수요일 MedRXiv에 실렸지만 아직 피어리뷰는 거치지 않아 https://t.co/lHPlWSUUhs
BREAKING: Coronavirus vaccine from Pfizer and BioNTech shows positive results https://t.co/kbrTQuoJd7
— CNBC Now (@CNBCnow) July 1, 2020
BREAKING: Coronavirus vaccine from Pfizer and BioNTech shows positive resultshttps://t.co/0lkEJwwx2f
— The Stock Sniper (@Ultra_Calls) July 1, 2020
Good news ??https://t.co/0DaBB560Uy
— Rajasekar (@sekartweets) July 1, 2020
BREAKING: #Coronavirus vaccine from #Pfizer and #BioNTech shows positive results - CNBC https://t.co/m3xEhPSo6r
— حسن سجواني ?? Hassan Sajwani (@HSajwanization) July 1, 2020
Pfizer, Biontech shares surge in pre-market trading after vaccine from the companies shows positive results https://t.co/Uyu94zmCFS pic.twitter.com/M2zUljRRGZ
— CNBC Now (@CNBCnow) July 1, 2020
Holy cow!!! You have all been waiting to hear. Me too!!!!!! https://t.co/UXsV56ytlC
— Andrew Rubin (@RubinHealth) July 1, 2020
BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/rdtySNR2oU
— FT Health (@fthealth) July 1, 2020
BioNTech & Pfizer's Covid trial: 24 people between 18-55 who received 2 doses of vaccine had “significantly elevated” antibodies within 4 weeks of 1st injection. Using messenger RNA (mRNA) technology which is faster than traditional vaccine development. https://t.co/dmPuVO9XO1
— Linda Yueh (@lindayueh) July 1, 2020
BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results
— Ajay Bagga (@Ajay_Bagga) July 1, 2020
https://t.co/BEKBVfU9SV
BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/ZGfRRZYppQ
— tyro (@DoubleEph) July 1, 2020
BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/3it5vdVojO
— Financial Times (@FT) July 1, 2020
GOOD-F*CKIN NEWS!
— Defeat Corona (@NoSylviaPlath) July 1, 2020
*considering the circumstances*
BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/sFX440bVUZ via @financialtimes
? SCOOP: BioNTech becomes the first ?? group to publish preliminary results of Covid-19 vaccine trial.
— Joe Miller (@JoeMillerJr) July 1, 2020
Participants in US study, with Pfizer, developed antibodies stronger than those of the average recovered Covid-19 patient.https://t.co/lZqRUYNHRR